XRX
41
-18
WMT
60
-15
PFE
31
-27
NVDA
46
-4
VIX
46
13
BMY
74
-2
YUM
56
-16
LRCX
49
-7
AME
62
-4
SLB
55
-5
T
29
-27
PHM
46
-18
URI
42
-26
PH
60
-15
STI
5
-41
DUK
55
3
RL
68
-15
XEL
39
-30
LOW
49
3
EA
44
-3
XRX
41
-18
WMT
60
-15
PFE
31
-27
NVDA
46
-4
VIX
46
13
BMY
74
-2
YUM
56
-16
LRCX
49
-7
AME
62
-4
SLB
55
-5
T
29
-27
PHM
46
-18
URI
42
-26
PH
60
-15
STI
5
-41
DUK
55
3
RL
68
-15
XEL
39
-30
LOW
49
3
EA
44
-3
Financhill
Back

Nuveen Pennsylvania Quality Municipal Income Fund Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
25

NQP
Nuveen Pennsylvania Quality Municipal Income Fund

Last Price:
$12.02
Seasonality Move:
1.8%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.71
Seasonality Move:
-18.07%
Sell
25
Nuveen Pennsylvania Quality Municipal Income Fund (NQP) is a Sell

Is Nuveen Pennsylvania Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen Pennsylvania Quality Municipal Income Fund [NQP] share price is $12.03. The Score for NQP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NQP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.71. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NQP Stock Price Chart

What is Nuveen Pennsylvania Quality Municipal Income Fund's stock price today?

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

NQP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 43.89 Sell
Chaikin Money Flow: 104200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.07 - 12.17) Sell
Bollinger Bands (100): (11.15 - 12.19) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.61 Sell
Chaikin Money Flow: -20975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.65) Sell
Bollinger Bands (100): (12.3 - 15.28) Sell

NQP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 12.11 Sell
50-day SMA: 12.09 Sell
200-day SMA: 11.41 Buy
8-day EMA: 12.07 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12 Buy
200-day EMA: 11.63 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.32 Sell
20-day SMA: 11.56 Buy
50-day SMA: 12.92 Sell
200-day SMA: 11.86 Sell
8-day EMA: 12.05 Sell
20-day EMA: 12.05 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.23 Sell

Nuveen Pennsylvania Quality Municipal Income Fund Earnings Growth & NQP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Nuveen Pennsylvania Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):